Nadeem Riaz

48PUBLICATIONS
302CO-AUTHORS
Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersRadiation and matterBiomedical imaging
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (48)

|May 29, 2026
Nonoperative Management of Locally Advanced Resectable Cutaneous Squamous Cell Cancer of the Head and Neck with PD-1 Blockade.

|Mar 27, 2026
POLQ-driven repair scars shape the immunogenic landscape of homologous recombination-deficient pancreatic cancer.

Wungki Park, Shigeaki Umeda, Marc Hilmi

|Mar 26, 2026
Pembrolizumab and olaparib in homologous-recombination-deficient metastatic pancreatic cancer: the phase 2 POLAR trial.

Wungki Park, Catherine A O'Connor, Joanne F Chou

|Jan 28, 2026
Genomic Enrichment and Functional Impact of TP53 and CYLD Alterations in Recurrent and Metastatic HPV-Associated Head and Neck Cancer.

Manu Prasad, Alex T Cheng, Marcel Mayer

|Jan 02, 2026
Tumor ecosystem and microbiome features associated with efficacy and resistance to avelumab plus chemoradiotherapy in head and neck cancer.

Nadeem Riaz, Tyler J Alban, Robert I Haddad

|Dec 12, 2025
Publisher Correction: APOBEC3 mutagenesis drives therapy resistance in breast cancer.

Avantika Gupta, Andrea Gazzo, Pier Selenica

Pageof 8

Frequent Collaborators

12 joint publications

Simon Powell

10 joint publications

Luc Morris

10 joint publications

Jorge S Reis-Filho

9 joint publications

Britta Weigelt